Top Headlines

GettyImages/utah778

US FDA approves drug duo pill for HIV

The US Food and Drug Administration has approved ViiV Healthcare’s two-drug treatment for HIV-1 maintenance, the first time the drugs have been combined into a single pill.

Promotional Features

SEDDS for oral peptide delivery: Gattefossé insight

Content provided by Gattefossé

SEDDS for oral peptide delivery: Gattefossé insight

Peptide therapeutics are on the rise due to their high potency, specific mode of action and safety. Currently, more than 60 peptides are available on the market. About 140 are in clinical trials and 500 are in preclinical development (Fosgerau and Hoffmann,...

Global Industry News

Hot Topics

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers